News Daily News CMS Greenlights Reimbursement for Renal Denervation Systems L.A. McKeown October 29, 2025
News Features Reimbursement Issues Seem to Be Holding Renal Denervation Back Todd Neale December 19, 2024
Presentation TCT 2024 TCT 480: Blood Pressure Reductions by Radiofrequency Renal Denervation Procedural Characteristics: Pooled 24-Month Results From the SYMPLICITY Clinical Program Presenter: Felix Mahfoud October 28, 2024
Presentation TCT 2024 The Body of Evidence: Safety, Efficacy and Sustainability of rf RDN Presenter: Felix Mahfoud October 28, 2024
Presentation TCT 2024 Setting the Standard: Patient Selection &the Safe and Effective Use of RDN Presenter: Tai Kobayashi October 28, 2024
Presentation TCT 2024 Hypertension State of Union and Role of RDN Presenter: Roxana Mehran October 28, 2024
News Conference News ESC 2024 New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower Yael L. Maxwell September 04, 2024
News Daily News Study Supports Cost-effectiveness of Renal Denervation for Hypertension Todd Neale August 23, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP L.A. McKeown April 16, 2024
News Daily News Symplicity Spyral Approved: FDA Clears Second Renal Denervation System Todd Neale November 20, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
Presentation TCT 2023 TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter Presenter: Felix Mahfoud October 25, 2023
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023